Your browser doesn't support javascript.
loading
Human antigen R as a therapeutic target in pathological cardiac hypertrophy.
Green, Lisa C; Anthony, Sarah R; Slone, Samuel; Lanzillotta, Lindsey; Nieman, Michelle L; Wu, Xiaoqing; Robbins, Nathan; Jones, Shannon M; Roy, Sudeshna; Owens, A Phillip; Aube, Jeffrey; Xu, Liang; Lorenz, John N; Blaxall, Burns C; Rubinstein, Jack; Benoit, Joshua B; Tranter, Michael.
Afiliación
  • Green LC; Department of Internal Medicine, Division of Cardiovascular Health and Disease and.
  • Anthony SR; Department of Pharmacology and Systems Physiology, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
  • Slone S; Department of Internal Medicine, Division of Cardiovascular Health and Disease and.
  • Lanzillotta L; Department of Internal Medicine, Division of Cardiovascular Health and Disease and.
  • Nieman ML; Department of Pharmacology and Systems Physiology, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
  • Wu X; Department of Internal Medicine, Division of Cardiovascular Health and Disease and.
  • Robbins N; Department of Pharmacology and Systems Physiology, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
  • Jones SM; Department of Molecular Biosciences, University of Kansas, Lawrence, Kansas, USA.
  • Roy S; Department of Internal Medicine, Division of Cardiovascular Health and Disease and.
  • Owens AP; Department of Internal Medicine, Division of Cardiovascular Health and Disease and.
  • Aube J; Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina, USA.
  • Xu L; Department of Internal Medicine, Division of Cardiovascular Health and Disease and.
  • Lorenz JN; Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina, USA.
  • Blaxall BC; Department of Molecular Biosciences, University of Kansas, Lawrence, Kansas, USA.
  • Rubinstein J; Department of Pharmacology and Systems Physiology, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
  • Benoit JB; Department of Pediatrics, Division of Molecular Cardiovascular Biology, Heart Institute, Cincinnati Children's Hospital Medical Center (CCHMC), Cincinnati, Ohio, USA.
  • Tranter M; Department of Internal Medicine, Division of Cardiovascular Health and Disease and.
JCI Insight ; 4(4)2019 02 21.
Article en En | MEDLINE | ID: mdl-30668549

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hipertrofia Ventricular Izquierda / Proteína 1 Similar a ELAV / Insuficiencia Cardíaca / Miocardio Límite: Animals / Humans / Male Idioma: En Revista: JCI Insight Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hipertrofia Ventricular Izquierda / Proteína 1 Similar a ELAV / Insuficiencia Cardíaca / Miocardio Límite: Animals / Humans / Male Idioma: En Revista: JCI Insight Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos